{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:38Z","timestamp":1779164558486,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jns.2016.12.033","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T11:16:30Z","timestamp":1482491790000},"page":"134-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity"],"prefix":"10.1016","volume":"373","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-5726","authenticated-orcid":false,"given":"Edgar","family":"Carnero Contentti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Pablo","family":"Hryb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-1051","authenticated-orcid":false,"given":"Sergio","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson","family":"Chiganer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Di Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Lessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Perassolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.12.033_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.12.033_bb0010","article-title":"Diagn\u00f3sticos diferenciales y pron\u00f3stico de las mielitis longitudinales extensas en Buenos Aires, Argentina","author":"Carnero Contentti","year":"2015","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.jns.2016.12.033_bb0015","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2016.12.033_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2016.12.033_bb0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1352458514551454","article-title":"Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis","volume":"21","author":"Hyun","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0030","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.12.033_bb0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnnp.2005.073247","article-title":"Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes","volume":"77","author":"Swanton","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.12.033_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jns.2016.12.033_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.12.033_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","author":"Transverse Myelitis Consortium Working Group (TMCW)","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.12.033_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2016.12.033_bb0060","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0065","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.12.033_bb0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.12.033_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458510382685","article-title":"Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica","volume":"17","author":"Lim","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458509106851","article-title":"Anti acquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients","volume":"15","author":"Fazio","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0085","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1352458509104585","article-title":"Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies","volume":"15","author":"Cabrera-Gomez","year":"2009","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jns.2016.12.033_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2013.5055","article-title":"Aquaporin 4 IgG Serostatus and outcome in recurrent longitudinally extensive transverse myelitis","volume":"71","author":"Yujuan","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2016.12.033_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.jns.2016.12.033_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.msard.2015.06.003","article-title":"Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: a meta-analysis","volume":"4","author":"Ruiz-Gaviria","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jns.2016.12.033_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1352458512451659","article-title":"Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies","volume":"19","author":"Chang","year":"2013","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jns.2016.12.033_bb0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/1352458512461968","article-title":"Analysis of prognostic factors associated with longitudinally extensive transverse myelitis","volume":"19","author":"Sep\u00falveda","year":"2013","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jns.2016.12.033_bb0115","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","article-title":"Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies","volume":"70","author":"Kitley","year":"2013","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.jns.2016.12.033_bb0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458514531087","article-title":"Magnetic resonance imaging in neuromyelitis optica","volume":"20","author":"Tackley","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0125","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2016.12.033_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.12.033_bb0135","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16308279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16308279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:46:05Z","timestamp":1758383165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16308279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":27,"alternative-id":["S0022510X16308279"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.12.033","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}